Overview

Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients

Status:
Completed
Trial end date:
2019-01-31
Target enrollment:
Participant gender:
Summary
This study evaluates whether individualized dosing schedule of inhaled bronchodilator is more effective than fixed dosing in reducing airway resistance of intubated COPD patients.
Phase:
N/A
Details
Lead Sponsor:
Shin-hwar Wu
Treatments:
Albuterol
Bronchodilator Agents
Fenoterol
Fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Salmeterol Xinafoate